Market Indices
Latest News
 |
| ||
|
Price Targets
from H.C. Wainwright issued a price target of $8.00 for CANF on 2026-07-02 10:41:00.The adjusted price target was set to $8.00.At the time of the announcement, CANF...
July 2, 2026 CANF -15.55%
from Goldman Sachs issued a price target of $169.00 for NTES on 2026-07-01 23:11:20.The adjusted price target was set to $169.00.At the time of the announcement, NTES...
July 1, 2026 NTES -1.90%
Kambiz Yazdi from BTIG issued a price target of $34.00 for KZIA on 2026-07-01 10:38:11.The adjusted price target was set to $34.00.At the time of the announcement, KZIA...
July 1, 2026 KZIA -1.05%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| YRD Yiren Digital Ltd. | 1.44
59.68% | ||||||||||||||||||
| CMMB Chemomab Therapeutics Ltd | 2.27
33.53% | ||||||||||||||||||
| MOGU MOGU Inc. | 2.05
13.26% | ||||||||||||||||||
| CLLS Cellectis S.A. | 3.30
12.24% | ||||||||||||||||||
| BNR Burning Rock Biotech Limi | 9.82
9.60% | ||||||||||||||||||
| WAVE Eco Wave Power Global AB | 9.25
8.57% | ||||||||||||||||||
| XTLB XTL Biopharmaceuticals Lt | 2.70
8.43% | ||||||||||||||||||
| SMMT Summit Therapeutics Inc. | 15.42
7.23% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 7.23%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 3.59%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 TEVA 3.59%